Spots Global Cancer Trial Database for high grade glioma
Every month we try and update this database with for high grade glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma | NCT05954858 | Glioma, Maligna... Glioblastoma Glioblastoma Mu... Glioblastoma Mu... High Grade Glio... GBM Brain Cancer | Tissue autograf... | 18 Years - | Northwell Health | |
| Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas | NCT03925246 | High Grade Glio... Brain Cancer | Nivolumab | 18 Years - 85 Years | Assistance Publique - Hôpitaux de Paris | |
| A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) | NCT03355794 | Diffuse Intrins... Malignant Gliom... High Grade Glio... Bithalamic High... Brainstem Gliom... Glioblastoma Anaplastic Astr... | ribociclib Everolimus | 12 Months - 30 Years | Children's Hospital Medical Center, Cincinnati | |
| 18F-Fluciclovine PET-MRI in High-grade Glioma | NCT05553041 | Glioma High Grade Glio... Glioma, Maligna... Glioma Intracra... Diffuse Glioma | 18F-Fluciclovin... | 1 Year - 21 Years | Children's Hospital of Philadelphia | |
| Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma | NCT04220892 | High Grade Glio... | Pembrolizumab Pemetrexed Abemaciclib | 18 Years - | Saint John's Cancer Institute | |
| A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma | NCT06016452 | Diffuse Glioma Radionecrosis o... High Grade Glio... Glioblastoma Mu... | Chlorophyllin | 18 Years - 70 Years | Tata Memorial Centre | |
| Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma | NCT02022644 | High Grade Glio... | nanoliposomal i... | 18 Years - | University of California, San Francisco | |
| Targeted Pediatric High-Grade Glioma Therapy | NCT05839379 | High Grade Glio... Diffuse Intrins... Anaplastic Astr... Glioblastoma Glioblastoma Mu... Diffuse Midline... Metastatic Brai... WHO Grade III G... WHO Grade IV Gl... | 12 Months - 39 Years | Nationwide Children's Hospital | ||
| Nivolumab for Recurrent or Progressive IDH Mutant Gliomas | NCT03557359 | Gliomas | Nivolumab | 18 Years - | Columbia University | |
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | NCT02858895 | Glioblastoma Grade IV Astroc... Glioblastoma Mu... Grade IV Glioma | MDNA55 | 18 Years - | Medicenna Therapeutics, Inc. | |
| REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma | NCT03690869 | Relapsed Solid ... Refractory Soli... Relapsed Centra... Refractory Cent... Diffuse Intrins... High Grade Glio... | cemiplimab (mon... cemiplimab (mai... Conventional or... Re-irradiation | - 25 Years | Regeneron Pharmaceuticals | |
| A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors | NCT04865315 | Low-grade Gliom... High Grade Glio... | 18 Years - | Maastricht Radiation Oncology | ||
| HUMC 1612: Optune NovoTTF-200A System | NCT03128047 | High Grade Glio... Ependymoma | Optune NovoTTF-... | 5 Years - 21 Years | Hackensack Meridian Health | |
| Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 | NCT01884740 | Glioblastoma Mu... Fibrillary Astr... Glioma of Brain... Anaplastic Astr... Pilomyxoid Astr... Mixed Oligodend... Brain Stem Glio... Diffuse Intrins... | SIACI of Erbitu... | 1 Year - 21 Years | Weill Medical College of Cornell University | |
| Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma | NCT04911621 | High Grade Glio... Diffuse Intrins... | Dendritic cell ... Dendritic cell ... | 12 Months - 17 Years | University Hospital, Antwerp | |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors | NCT02684058 | Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Ipon... | Dabrafenib trametinib Carboplatin Vincristine | 12 Months - 17 Years | Novartis | |
| Glioma and Exercising | NCT03775369 | High Grade Glio... | endurance train... social support ... resistance trai... | 18 Years - 75 Years | University Hospital, Basel, Switzerland | |
| Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG | NCT05773326 | High Grade Glio... Glioma Glioma, Maligna... Glioblastoma | Temsirolimus | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma | NCT01390948 | High Grade Glio... | Bevacizumab Radiotherapy Temozolomide (T... | 6 Months - 18 Years | Hoffmann-La Roche | |
| A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors | NCT04865315 | Low-grade Gliom... High Grade Glio... | 18 Years - | Maastricht Radiation Oncology | ||
| SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue | NCT04734444 | Brain Tumour High Grade Glio... Low-grade Gliom... Glioblastoma | SonoClear ACF | 18 Years - | SonoClear AS | |
| Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas | NCT02795364 | Glioma Anaplastic Olig... Glioblastomas (... | Structural Imag... Metabolic Image... | 18 Years - 70 Years | Huashan Hospital | |
| Pediatric Long-Term Follow-up and Rollover Study | NCT03975829 | Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Lipo... Neurofibromatos... | dabrafenib trametinib | 1 Year - | Novartis | |
| Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma | NCT00826930 | High Grade Glio... | Trans Sodium Cr... | 18 Years - | Diffusion Pharmaceuticals Inc | |
| Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) | NCT01906385 | Glioma | Rhenium Liposom... | 18 Years - | Plus Therapeutics | |
| Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma | NCT00897611 | High Grade Glio... | DNA methylation... polymerase chai... computed tomogr... magnetic resona... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Pediatric Long-Term Follow-up and Rollover Study | NCT03975829 | Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Lipo... Neurofibromatos... | dabrafenib trametinib | 1 Year - | Novartis | |
| Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 | NCT01884740 | Glioblastoma Mu... Fibrillary Astr... Glioma of Brain... Anaplastic Astr... Pilomyxoid Astr... Mixed Oligodend... Brain Stem Glio... Diffuse Intrins... | SIACI of Erbitu... | 1 Year - 21 Years | Weill Medical College of Cornell University | |
| Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma | NCT00589875 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio... | CAN-2409 Valacyclovir Temozolomide Radiation thera... | 18 Years - | Candel Therapeutics, Inc. | |
| rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG | NCT04943848 | Diffuse Intrins... Diffuse Midline... | rHSC-DIPGVax Balstilimab Zalifrelimab | 12 Months - 18 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Positron Emission Tomography-Computed Tomography (PET-CT) High-grade Glioma | NCT00643591 | Cerebral Astroc... | imaging (dynami... | 19 Years - | Maastricht Radiation Oncology | |
| Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 | NCT02655601 | High Grade Glio... Astrocytoma, Gr... Glioblastoma | BMX-001 Radiation Thera... Temozolomide | 18 Years - | BioMimetix JV, LLC | |
| MRI in High-Grade Glioma Patients Undergoing Chemoradiation | NCT05212272 | High Grade Glio... | PET-MRI Brain S... Blood draw Memory testing Optional lumbar... | 18 Years - | Wake Forest University Health Sciences | |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | NCT04655404 | High Grade Glio... Diffuse Intrins... | Larotrectinib Larotrectinib s... | - 21 Years | Nationwide Children's Hospital | |
| Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas | NCT02041611 | High Grade Glio... | Blood collectio... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment | NCT05460507 | Glioma | Retreatment Rhe... | 18 Years - | Plus Therapeutics | |
| Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas | NCT02795364 | Glioma Anaplastic Olig... Glioblastomas (... | Structural Imag... Metabolic Image... | 18 Years - 70 Years | Huashan Hospital | |
| Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents | NCT01517776 | Gliomas | Cilengitide Temozolomide | 3 Years - 17 Years | Martin-Luther-Universität Halle-Wittenberg | |
| Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children | NCT02885324 | Glioblastoma Mu... Anaplastic Astr... Malignant Brain... High Grade Glio... | Cabozantinib | 2 Years - 21 Years | Indiana University | |
| Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma | NCT01808820 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 13 Years - 99 Years | University of Miami | |
| A Phase I Study of ECO-4601 in Patients With Advanced Cancer | NCT00338026 | Tumors Glioma Colorectal Canc... Lung Cancer Breast Cancer Ovarian Cancer Pancreatic Canc... Prostate Cancer | ECO-4601 | 18 Years - | Thallion Pharmaceuticals | |
| Study of DSP-0390 in Patients With Recurrent High-Grade Glioma | NCT05023551 | High Grade Glio... Glioblastoma Mu... | DSP-0390 | 18 Years - | Sumitomo Pharma America, Inc. | |
| Study of Ribociclib and Everolimus in HGG and DIPG | NCT05843253 | High Grade Glio... Diffuse Intrins... Anaplastic Astr... Glioblastoma Glioblastoma Mu... Diffuse Midline... Metastatic Brai... WHO Grade III G... WHO Grade IV Gl... | Ribociclib Everolimus | 12 Months - 39 Years | Nationwide Children's Hospital | |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors | NCT02684058 | Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Ipon... | Dabrafenib trametinib Carboplatin Vincristine | 12 Months - 17 Years | Novartis | |
| 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas | NCT05850377 | High Grade Glio... Glioma Glioma, Maligna... Neoplasms, Neur... Neuroectodermal... Photosensitizin... Neoplasm Malign... Brain Neoplasms... Central Nervous... Brain Tumor Tumour, Residua... | 5-Aminolevulini... Fluorescence-Gu... | 18 Years - 75 Years | Sociedad de Lucha Contra el Cáncer del Ecuador | |
| Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | NCT06333899 | High Grade Glio... Diffuse Intrins... Anaplastic Astr... Infant Type Hem... Glioblastoma Glioblastoma Mu... WHO Grade III G... WHO Grade IV Gl... Diffuse Midline... | Lorlatinib Lorlatinib with... Lorlatinib with... Lorlatinib post... | 1 Year - 21 Years | Nationwide Children's Hospital | |
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | NCT02858895 | Glioblastoma Grade IV Astroc... Glioblastoma Mu... Grade IV Glioma | MDNA55 | 18 Years - | Medicenna Therapeutics, Inc. | |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | NCT04655404 | High Grade Glio... Diffuse Intrins... | Larotrectinib Larotrectinib s... | - 21 Years | Nationwide Children's Hospital | |
| BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels | NCT05375318 | Astrocytoma, Gr... Glioblastoma Glioblastoma Mu... Glioblastoma, I... Glioblastoma, I... Glioblastoma ID... Glioblastoma ID... High Grade Glio... | 18 Years - | Universitat Politècnica de València | ||
| Low Dose Radiation Therapy for Glioblastoma Multiforme | NCT01466686 | High Grade Glio... | Low Dose Fracti... Temozolomide | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma | NCT01808820 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 13 Years - 99 Years | University of Miami | |
| Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma | NCT02278510 | Malignant Gliom... WHO Grade III o... | Topotecan Gadolinium DTPA Cleveland Multi... | 18 Years - | Case Comprehensive Cancer Center | |
| Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma | NCT05954858 | Glioma, Maligna... Glioblastoma Glioblastoma Mu... Glioblastoma Mu... High Grade Glio... GBM Brain Cancer | Tissue autograf... | 18 Years - | Northwell Health | |
| Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas | NCT02473484 | Glioblastoma | 18 Years - | University Hospital, Lille | ||
| A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors | NCT06357377 | Pediatric Tumor... Pediatric Tumor... Diffuse Midline... Pediatric Tumor... Pineocytoma Choroid Plexus ... Spinal Cord Tum... High Grade Glio... | NEO100 | 5 Years - 18 Years | Neonc Technologies, Inc. | |
| Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors | NCT02644291 | Medulloblastoma Astrocytoma, Gr... Glioblastoma Anaplastic Astr... Brain Stem Neop... Oligodendroblas... Anaplastic Olig... Malignant Gliom... | Mebendazole | 1 Year - 21 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013) | NCT03243461 | Glioblastoma WH... Diffuse Midline... Anaplastic Astr... Diffuse Intrins... Gliomatosis Cer... | Temozolomide + ... | 3 Years - 17 Years | University of Göttingen | |
| Personalized Translational Platform for Biomarker Discovery in Brain Tumors | NCT01240161 | High Grade Glio... | FLT-PET/CT: (3'... | 18 Years - 85 Years | Brigham and Women's Hospital | |
| Sorafenib in Newly Diagnosed High Grade Glioma | NCT00884416 | Glioblastoma Gliosarcoma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Sorafenib dose ... | 18 Years - | University Hospital, Geneva | |
| Glioma Supra Marginal Incision Trial | NCT04737577 | High Grade Glio... | Supramarginal r... Conventional (i... | 18 Years - 85 Years | Sunnybrook Health Sciences Centre | |
| 18F-Fluciclovine PET-MRI in High-grade Glioma | NCT05553041 | Glioma High Grade Glio... Glioma, Maligna... Glioma Intracra... Diffuse Glioma | 18F-Fluciclovin... | 1 Year - 21 Years | Children's Hospital of Philadelphia | |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | NCT04655404 | High Grade Glio... Diffuse Intrins... | Larotrectinib Larotrectinib s... | - 21 Years | Nationwide Children's Hospital | |
| Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas | NCT04766632 | High Grade Glio... | Brain PET-CT of... | 18 Years - 75 Years | Central Hospital, Nancy, France | |
| Coping With High Grade Glioma | NCT00815152 | Glioma | coping skills i... usual care | 18 Years - | Duke University | |
| The Effects of Adding a Home Exercise Program to a Clinical Physical Therapy Program on Cancer-Related Fatigue | NCT00840554 | Fatigue | Clinic-based ph... Home exercise p... | 18 Years - | University of Florida | |
| Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients | NCT01836536 | Glioblastoma Glioma | Bevacizumab sta... | 18 Years - | Center Eugene Marquis | |
| Low Dose Radiation Therapy for Glioblastoma Multiforme | NCT01466686 | High Grade Glio... | Low Dose Fracti... Temozolomide | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor | NCT01470794 | Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Toca 511 vector Toca FC | 18 Years - 80 Years | Tocagen Inc. | |
| Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma | NCT00003535 | High Grade Glio... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma | NCT00003535 | High Grade Glio... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma | NCT03927274 | Glioma of Brain | Topotecan | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma | NCT00826930 | High Grade Glio... | Trans Sodium Cr... | 18 Years - | Diffusion Pharmaceuticals Inc | |
| Pediatric Long-Term Follow-up and Rollover Study | NCT03975829 | Diffuse Astrocy... Anaplastic Astr... Astrocytoma Oligodendroglio... Anaplastic Olig... Glioblastoma Pilocytic Astro... Giant Cell Astr... Pleomorphic Xan... Anaplastic Pleo... Angiocentric Gl... Chordoid Glioma... Gangliocytoma Ganglioglioma Anaplastic Gang... Dysplastic Gang... Desmoplastic In... Papillary Glion... Rosette-forming... Central Neurocy... Extraventricula... Cerebellar Lipo... Neurofibromatos... | dabrafenib trametinib | 1 Year - | Novartis | |
| Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) | NCT04485559 | Recurrent World... Low-grade Gliom... High Grade Glio... | Everolimus Trametinib | 1 Year - 25 Years | University of California, San Francisco | |
| Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 | NCT02655601 | High Grade Glio... Astrocytoma, Gr... Glioblastoma | BMX-001 Radiation Thera... Temozolomide | 18 Years - | BioMimetix JV, LLC | |
| Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients | NCT03849430 | Glioma of Brain | 18 Years - | Universitaire Ziekenhuizen KU Leuven | ||
| STARLITE for Unresectable High-Grade Gliomas | NCT06428045 | High Grade Glio... | Magnetic Resona... Abacavir Lamivudine Ritonavir Temozolomide Focal Radiother... | 18 Years - | University of Miami | |
| Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) | NCT05979064 | Glioma Glioma, Maligna... Glioblastoma Glioblastoma Mu... Glioblastoma Mu... GBM Brain Cancer High Grade Glio... | Laparoscopicall... | 18 Years - | Northwell Health | |
| Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma | NCT00589875 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio... | CAN-2409 Valacyclovir Temozolomide Radiation thera... | 18 Years - | Candel Therapeutics, Inc. | |
| A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas | NCT05082493 | High Grade Glio... | Berubicin Hydro... | 2 Years - 18 Years | WPD Pharmaceuticals Sp. z o.o. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
